Breast cancer cells have lower activating protein 1 transcription factor activity than normal mammary epithelial cells.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Cancer Research

• Publication date

  1997-07-15

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 9230221
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Oncogenes and Tumor Suppressor Genes in Human Malignancies

  2012cited by this paper
• Activation and inhibition of the AP‐1 complex in human breast cancer cells

  1996cited by this paper
• Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis

  1996cited by this paper
• Transactivation activity of Maf nuclear oncoprotein is modulated by Jun, Fos and small Maf proteins.

  1996cited by this paper
• Antitumor promotion by phenolic antioxidants: inhibition of AP-1 activity through induction of Fra expression.

  1995cited by this paper
• Neu differentiation factor/heregulin modulates growth and differentiation of HC11 mammary epithelial cells.

  1995cited by this paper
• Opposing Effects of ERK and JNK-p38 MAP Kinases on Apoptosis

  1995cited by this paper
• Blocking of tumor promoter-induced AP-1 activity inhibits induced transformation in JB6 mouse epidermal cells.

  1994cited by this paper
• Mouse JunD negatively regulates fibroblast growth and antagonizes transformation by ras.

  1994cited by this paper
• Constitutive ap‐1 dna binding and transactivating ability of malignant but not benign mouse epidermal cells

  1994cited by this paper
• Maf and Nrl can bind to AP-1 sites and form heterodimers with Fos and Jun.

  1994cited by this paper
• c-fos and c-jun overexpression in malignant cells reduces their tumorigenic and metastatic potential, and affects their MHC class I gene expression.

  1994cited by this paper
• Nuclear receptor/AP-1 interaction.

  1993cited by this paper
• Cross‐coupling of the NF‐kappa B p65 and Fos/Jun transcription factors produces potentiated biological function.

  1993cited by this paper
• Blockage of EGF receptor signal transduction causes reversible arrest of normal and immortal human mammary epithelial cells with synchronous reentry into the cell cycle.

  1993cited by this paper
• Oncogenes, tumour suppressor genes and growth factors in breast cancer: novel targets for diagnosis, prognosis and therapy.

  1993cited by this paper
• The insulin-like growth factor family of ligands, receptors, and binding proteins

  1992cited by this paper
• Pleiotropic actions of suramin on the proliferation of human breast‐cancer cells in vitro

  1992cited by this paper
• Factors Influencing Growth and Differentiation of Normal and Transformed Human Mammary Epithelial Cells in Culture

  1992cited by this paper
• Direct stimulation by estrogen of growth factor signal transduction pathways in human breast cancer cells.

  1992cited by this paper
• Transformation of Human Breast Epithelial Cells by c‐Ha‐ras Oncogene

  1991influential reference
• c-JUN, JUN B, and JUN D differ in their binding affinities to AP-1 and CRE consensus sequences: effect of FOS proteins.

  1991cited by this paper
• Oestrogen directly stimulates growth factor signal transduction pathways in human breast cancer cells.

  1991cited by this paper
• The role of jun and fos gene family members in 12-O-tetradecanoylphorbol-13-acetate induced hemopoietic differentiation.

  1991cited by this paper
• A naturally occurring truncated form of FosB that inhibits Fos/Jun transcriptional activity.

  1991cited by this paper
• The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation.

  1991cited by this paper
• Ha-Ras augments c-Jun activity and stimulates phosphorylation of its activation domain

  1991cited by this paper
• Expression of the transforming growth factor-alpha/epidermal growth factor receptor pathway in normal human breast epithelial cells.

  1990cited by this paper
• Ultrastructural and immunocytochemical characterization of an immortalized human breast epithelial cell line, MCF-10.

  1990cited by this paper
• Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10.

  1990cited by this paper
• Heterodimer formation between CREB and JUN proteins.

  1990cited by this paper
• jun-B inhibits and c-fos stimulates the transforming and trans-activating activities of c-jun.

  1989cited by this paper
• Jun-B differs in its biological properties from, and is a negative regulator of, c-Jun.

  1989cited by this paper
• Chromosome analyses of human mammary epithelial cells at stages of chemical-induced transformation progression to immortality.

  1989cited by this paper
• Expression of raf oncogenes activates the PEA1 transcription factor motif

  1989cited by this paper
• Activation of the neu tyrosine kinase induces the fos/jun transcription factor complex, the glucose transporter and ornithine decarboxylase

  1989cited by this paper
• Transforming growth factor alpha production and epidermal growth factor receptor expression in normal and oncogene transformed human mammary epithelial cells.

  1989cited by this paper
• Induction of proto-oncogene JUN/AP-1 by serum and TPA

  1988cited by this paper
• Activation of the c-fos gene by UV and phorbol ester: different signal transduction pathways converge to the same enhancer element.

  1988cited by this paper
• Requirement for fos gene expression in the transcriptional activation of collagenase by other oncogenes and phorbol esters.

  1988cited by this paper
• c-Jun dimerizes with itself and with c-Fos, forming complexes of different DNA binding affinities.

  1988cited by this paper
• Estrogenic regulation of growth and polypeptide growth factor secretion in human breast carcinoma.

  1987cited by this paper
• Phorbol esters inhibit the proliferation of MCF-7 cells. Possible implication of protein kinase C.

  1986cited by this paper
• Transient induction of c-fos and c-myc in an immediate consequence of growth factor stimulation.

  1985cited by this paper
• Induction of transformation and continuous cell lines from normal human mammary epithelial cells after exposure to benzo[a]pyrene.

  1985cited by this paper
• Stimulation and inhibition of growth by EGF in different A431 cell clones is accompanied by the rapid induction of c‐fos and c‐myc proto‐oncogenes.

  1985cited by this paper
• Antagonism between epidermal growth factor and phorbol ester tumor promoters in human breast cancer cells.

  1981cited by this paper
• Growth of normal human mammary cells in culture

  1980cited by this paper
• Effects of vitamin A and its analogs (retinoids) on normal and neoplastic cells.

  1980cited by this paper
• Different susceptibilities of human melanoma and breast carcinoma cell lines to retinoic acid-induced growth inhibition.

  1979cited by this paper

• Targeting lung cancer with clinically relevant EGFR mutations using anti-EGFR RNA aptamer

  2023cites this paper
• The initial expression alterations occurring to transcription factors during the formation of breast cancer: Evidence from bioinformatics

  2022cites this paper
• Aptamers with Tunable Affinity Enable Single‐Molecule Tracking and Localization of Membrane Receptors on Living Cancer Cells

  2020cites this paper
• c-Jun suppresses the expression of WNT inhibitory factor 1 through transcriptional regulation and interaction with DNA methyltransferase 1 in gallbladder cancer

  2018cites this paper
• Radiation-induced acid ceramidase confers prostate cancer resistance and tumor relapse.

  2013cites this paper
• Expression of activator protein-1 (AP-1) family members in breast cancer

  2013cites this paper
• Aberrant Expression of Fra-1 in Estrogen Receptor-negative Breast Cancers and Suppression of their Propagation In Vivo by Ascochlorin, an Antibiotic that Inhibits Cellular Activator Protein-1 Activity

  2007cites this paper
• Jun and Fos family protein expression in human breast cancer: correlation of protein expression and clinicopathological parameters.

  2006cites this paper
• Dual signaling mechanisms of estrogen: Phosphorylation of P53 at Ser15 in aging HMEC in the absence of estrogen receptor

  2005cites this paper
• The HER2/Grb2/Akt pathway regulates the DNA binding activity of AP-1 in breast cancer cells.

  2004cites this paper
• Role of Retinoid Receptors in the Prevention and Treatment of Breast Cancer

  2004cites this paper
• Activity of MDI-301, a novel synthetic retinoid, in xenografts

  2004cites this paper
• In Vitro Models for Human Breast Cancer

  2004cites this paper
• From Mice to Humans

  2004cites this paper
• Relevance of mitogen activated protein kinase (MAPK) and phosphotidylinositol-3-kinase/protein kinase B (PI3K/PKB) pathways to induction of apoptosis by curcumin in breast cells.

  2003cites this paper
• cDNA Microarray Analysis of Chronic Myeloid Leukemia

  2002cites this paper
• Hormonal regulation of the c‐fms proto‐oncogene in breast cancer cells is mediated by a composite glucocorticoid response element

  2002cites this paper
• AP-1 blockade inhibits the growth of normal and malignant breast cells

  2001cites this paper
• The Role of Angiogenesis in Breast Cancer Progression

  2001cites this paper
• Effect of malignant transformation on lactate levels of human mammary epithelial cells.

  2001cites this paper
• Differences between human breast cell lines in susceptibility towards growth inhibition by genistein

  2001cites this paper
• Xenograft Models of Premalignant Breast Disease

  2000cites this paper
• Chemoprevention of breast cancer

  2000cites this paper
• Activator Protein-1 Mediates Induced but not Basal Epidermal Growth Factor Receptor Gene Expression

  2000cites this paper
• Studies of the mechanisms of action of the cancer chemopreventive agent genistein

  2000cites this paper
• The Role of Sp1 in the Differential Expression of Transforming Growth Factor-β Receptor Type II in Human Breast Adenocarcinoma MCF-7 Cells*

  2000cites this paper
• Alteration of Jun proto‐oncogene status by plasmid transfection affects growth of human ovarian cancer cells

  1999cites this paper
• cJun overexpression in MCF-7 breast cancer cells produces a tumorigenic, invasive and hormone resistant phenotype

  1999cites this paper
• Malignant transformation alters membrane choline phospholipid metabolism of human mammary epithelial cells.

  1999cites this paper
• Monitoring gene expression profile changes in ovarian carcinomas using cDNA microarray.

  1999cites this paper
• Tamoxifen prevention of breast cancer: an instance of the fingerpost.

  1999cites this paper
• Retinoic acid receptor antagonist BMS453 inhibits the growth of normal and malignant breast cells without activating RAR–dependent gene expression

  1999cites this paper
• Actions of heparin that may affect the malignant process

  1999cites this paper
• Re-expression of SPR1 in Breast Cancer Cells by Phorbol 12-Myristate 13-Acetate (PMA) or UV Irradiation Is Mediated by the AP-1 Binding Site in the SPR1 Promoter

  1999cites this paper
• Gap junction Cx26 gene modulation by phorbol esters in benign and malignant human mammary cells.

  1998cites this paper
• Correlation between cell cycle regulators and the immortalization and transformation of human breast epithelial cell lines.

  1998cites this paper
• Prevention of Breast Cell Transformation by Blockade of the AP-1 Transcription Factor

  1997cites this paper
• Human Mammary Cell Resource.

  1996cites this paper